Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
67
NUTX Quote, Financials, Valuation and Earnings
Last price:
$156.65
Seasonality move
:
-10.17%
Day range:
$132.42 - $157.29
52-week range:
$28.12 - $184.28
Dividend yield:
0%
P/E ratio:
8.45x
P/S ratio:
0.98x
P/B ratio:
3.50x
Volume:
290.3K
Avg. volume:
159.5K
1-year change:
300.69%
Market cap:
$1.1B
Revenue:
$479.9M
EPS (TTM):
$18.54
Analysts' Opinion
-
Consensus RatingNutex Health, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $250.00, Nutex Health, Inc. has an estimated upside of 59.45% from its current price of $156.79.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $220.00 representing -40.32% downside risk from its current price of $156.79.
Fair Value
-
According to the consensus of 2 analysts, Nutex Health, Inc. has 59.45% upside to fair value with a price target of $250.00 per share.
NUTX vs. S&P 500
-
Over the past 5 trading days, Nutex Health, Inc. has overperformed the S&P 500 by 38.84% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nutex Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nutex Health, Inc. has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Nutex Health, Inc. reported revenues of $267.8M.
Earnings Growth
-
Nutex Health, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Nutex Health, Inc. reported earnings per share of $7.76.
Enterprise value:
1.4B
EV / Invested capital:
1.79x
Price / LTM sales:
0.98x
EV / EBIT:
4.06x
EV / Revenue:
1.45x
PEG ratio (5yr expected):
--
EV / Free cash flow:
8.07x
Price / Operating cash flow:
5.46x
Enterprise value / EBITDA:
3.83x
Gross Profit (TTM):
$539.8M
Return On Assets:
34.43%
Net Income Margin (TTM):
26.16%
Return On Equity:
97.36%
Return On Invested Capital:
42.69%
Operating Margin:
48.68%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $231.7M | $292M | $981.2M | $78.8M | $267.8M | |
| Gross Profit | $22.1M | $67.8M | $539.8M | $21.9M | $154.9M | |
| Operating Income | -$11.1M | $27.6M | $350.5M | $10.1M | $130.4M | |
| EBITDA | $5.1M | $46M | $371.2M | $15.1M | $135.4M | |
| Diluted EPS | -$6.63 | -$8.86 | $18.54 | -$1.72 | $7.76 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $11.6M | $107.5M | $89.9M | $119.8M | $592.7M | |
| Total Assets | $83.3M | $434.5M | $479.6M | $438.5M | $964.5M | |
| Current Liabilities | $6.5M | $43.8M | $67.3M | $67.6M | $185.5M | |
| Total Liabilities | $9.3M | $302M | $374.7M | $358.7M | $526.5M | |
| Total Equity | $73.9M | $132.5M | $104.9M | $79.8M | $438M | |
| Total Debt | $3.2M | $257.5M | $322.8M | $297.8M | $351.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $7.5M | $21.3M | $177.8M | $6.8M | $99.5M | |
| Cash From Investing | -$4.2M | -$1.4M | -$3.5M | -$267.2K | -$302K | |
| Cash From Financing | -$13.1M | $162.8K | -$55.1M | -$421K | -$29.9M | |
| Free Cash Flow | $5.1M | $20.2M | $176.3M | $6.2M | $99.2M | |
NUTX
Sector
Market Cap
$1.1B
$28.8M
Price % of 52-Week High
85.09%
51.13%
Dividend Yield
0%
0%
Shareholder Yield
-2.18%
-1.32%
1-Year Price Total Return
300.69%
-20.64%
Beta (5-Year)
-0.034
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$127.78
200-day SMA
Buy
Level
$105.57
Bollinger Bands (100)
Buy
Level
88.47 - 119.95
Chaikin Money Flow
Buy
Level
1M
20-day SMA
Buy
Level
$121.08
Relative Strength Index (RSI14)
Buy
Level
66.26
ADX Line
Buy
Level
22.79
Williams %R
Sell
Level
-1.904
50-day SMA
Buy
Level
$115.36
MACD (12, 26)
Buy
Level
5.64
25-day Aroon Oscillator
Buy
Level
8
On Balance Volume
Neutral
Level
3.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0562)
Sell
CA Score
(Annual)
Level (-0.5205)
Sell
Beneish M-Score
(Annual)
Level (-0.4913)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.2084)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.
Stock Forecast FAQ
In the current month, NUTX has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NUTX average analyst price target in the past 3 months is $250.00.
-
Where Will Nutex Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nutex Health, Inc. share price will rise to $250.00 per share over the next 12 months.
-
What Do Analysts Say About Nutex Health, Inc.?
Analysts are divided on their view about Nutex Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nutex Health, Inc. is a Sell and believe this share price will drop from its current level to $220.00.
-
What Is Nutex Health, Inc.'s Price Target?
The price target for Nutex Health, Inc. over the next 1-year time period is forecast to be $250.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NUTX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nutex Health, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NUTX?
You can purchase shares of Nutex Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nutex Health, Inc. shares.
-
What Is The Nutex Health, Inc. Share Price Today?
Nutex Health, Inc. was last trading at $156.65 per share. This represents the most recent stock quote for Nutex Health, Inc.. Yesterday, Nutex Health, Inc. closed at $156.79 per share.
-
How To Buy Nutex Health, Inc. Stock Online?
In order to purchase Nutex Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NUTX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NUTX
Sector
P/E ratio
8.45x
23.71x
PEG ratio
--
-0.01x
P/B ratio
3.50x
1.84x
Price / LTM sales
0.98x
1.60x
Growth Metrics
NUTX
Sector
Revenue growth
239.88%
4.85%
Earnings growth
550.38%
11.15%
Revenue (5-year growth)
222.94%
6.45%
Earnings forecast
$1.95
-$0.20
Profitability
NUTX
Sector
Profitability FY 2024
$196.3M
$3.6M
Return on invested capital
42.69%
-30.98%
Return on assets
34.43%
-27.62%
Return on equity
97.36%
-36.69%
Earnings Date
Last Earnings Date
Nov
18
Next Earnings Date
Dec
5
Estimated Next Earnings Date
Mar
6
Balance Sheet
NUTX
Sector
Total cash
$166M
$27.2M
Short term investments
--
$25.7M
Total assets
$721.9M
$79.7M
Long term debt
$351.2M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
